Suchergebnisse - "Pieczonka, Christopher M"

PubPharm (21)

1

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN

enthalten in: British journal of cancer | 2024

von Shen, J. | Chowdhury, S. | Agarwal, N. | +16

2

Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer

enthalten in: NEJM evidence | 2023

von Freedland, S. | Gleave, M. | De Giorgi, U. | +14

3

Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer

enthalten in: Urologic oncology | 2023

von Shore, N. | Polikarpov, D. | Pieczonka, C. | +16

4

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

enthalten in: The New England journal of medicine | 2023

von Freedland, S. | de Almeida Luz, M. | De Giorgi, U. | +17

CommentIn: N Engl J Med. 2024 Jan 4;390(1):90. - PMID 38169497

5

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer : STAMP and STRIDE Trials

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Antonarakis, E. | Subudhi, S. | Pieczonka, C. | +8

6

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy : outcomes from the PROCEED registry

enthalten in: Prostate cancer and prostatic diseases | 2020

von Sartor, O. | Armstrong, A. | Ahaghotu, C. | +19

7

Development and evaluation of the MiCheck test for aggressive prostate cancer

enthalten in: Urologic oncology | 2020

von Shore, N. | Pieczonka, C. | Henderson, R. | +12

8

A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial

enthalten in: Urologic oncology | 2020

von Shore, N. | Pieczonka, C. | Henderson, R. | +14

9

Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data

enthalten in: Cancer | 2020

von Higano, C. | Armstrong, A. | Sartor, O. | +18

CommentOn: Cancer. 2019 Dec 1;125(23):4172-4180. - PMID 31483485

10

Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer

enthalten in: Cancer | 2019

von Higano, C. | Armstrong, A. | Sartor, A. | +18

CommentIn: Cancer. 2020 Jun 15;126(12):2935-2937. - PMID 32154908